Role of Th1 and Th2 cytokines in BCG-induced IFN-gamma production: cytokine promotion and simulation of BCG effect (Q40659843)

22 September 2017

title

Role of Th1 and Th2 cytokines in BCG-induced IFN-gamma production: cytokine promotion and simulation of BCG effect (English)

1 reference

22 September 2017

Yi Luo

1

1 reference

22 September 2017

Xiaohong Chen

series ordinal

2

1 reference

22 September 2017

Michael A O'Donnell

series ordinal

3

1 reference

22 September 2017

publication date

1 January 2003

1 reference

22 September 2017

1 reference

22 September 2017

volume

21

1 reference

22 September 2017

issue

1

1 reference

22 September 2017

page(s)

17-26

1 reference

BCG immunotherapy of bladder cancer: 20 years on.

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1043-4666%2802%2900490-8

7 January 2021

Elevations of cytokines interleukin-1, interleukin-2 and tumor necrosis factor in the urine of patients after intravesical bacillus Calmette-Guerin immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1043-4666%2802%2900490-8

7 January 2021

Radio-immunoassay detection of interferon-gamma in urine after intravesical Evans BCG therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1043-4666%2802%2900490-8

7 January 2021

Urinary Interleukin-8 and 18 predict the response of superficial bladder cancer to intravesical therapy with bacillus Calmette-Guerin

1 reference

https://api.crossref.org/works/10.1016%2FS1043-4666%2802%2900490-8

7 January 2021

BCG-induced urinary cytokines inhibit microvascular endothelial cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS1043-4666%2802%2900490-8

7 January 2021

Intravesical bacille Calmette-Guérin induces the antiangiogenic chemokine interferon-inducible protein 10.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-4666%2802%2900490-8

7 January 2021

IFN-gamma and IL-12 but not IL-10 are required for local tumour surveillance in a syngeneic model of orthotopic bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1043-4666%2802%2900490-8

7 January 2021

Induction of TH1- and TH2-associated cytokine mRNA in mouse bladder following intravesical growth of the murine bladder tumor MB49 and BCG immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1043-4666%2802%2900490-8

7 January 2021

T-cell subsets required for intravesical BCG immunotherapy for bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1043-4666%2802%2900490-8

7 January 2021

Long-term complete remission in bladder carcinoma in situ with intravesical TICE bacillus Calmette Guerin. Overview analysis of six phase II clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS1043-4666%2802%2900490-8

7 January 2021

Long-term effect of intravesical bacillus Calmette-Guerin on flat carcinoma in situ of the bladder

1 reference

https://api.crossref.org/works/10.1016%2FS1043-4666%2802%2900490-8

7 January 2021

BCG therapy in superficial bladder tumours--complications and precautions

1 reference

https://api.crossref.org/works/10.1016%2FS1043-4666%2802%2900490-8

7 January 2021

Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1043-4666%2802%2900490-8

7 January 2021

Interleukin-12. Opportunities for the treatment of bladder cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-4666%2802%2900490-8

7 January 2021

Bacillus Calmette-Guérin plus intravesical interferon alpha-2b in patients with superficial bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1043-4666%2802%2900490-8

7 January 2021

Treatment of transitional cell carcinoma of the bladder with intravesical interleukin-2: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS1043-4666%2802%2900490-8

7 January 2021

Intravesical recombinant tumor necrosis factor in the treatment of superficial bladder cancer: an Eastern Cooperative Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS1043-4666%2802%2900490-8

7 January 2021

Bacillus Calmette-Guérin plus interleukin-2 and/or granulocyte/macrophage-colony-stimulating factor enhances immunocompetent cell production of interferon-gamma, which inhibits B16F10 melanoma cell growth in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1043-4666%2802%2900490-8

7 January 2021

Interleukin 12 acts directly on CD4+ T cells to enhance priming for interferon gamma production and diminishes interleukin 4 inhibition of such priming

1 reference

https://api.crossref.org/works/10.1016%2FS1043-4666%2802%2900490-8

7 January 2021

Natural killer cells are a source of interferon gamma that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania major in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1043-4666%2802%2900490-8

7 January 2021

Induction of interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers

1 reference

https://api.crossref.org/works/10.1016%2FS1043-4666%2802%2900490-8

7 January 2021

Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1043-4666%2802%2900490-8

7 January 2021

Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1043-4666%2802%2900490-8

7 January 2021

Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells

1 reference

https://api.crossref.org/works/10.1016%2FS1043-4666%2802%2900490-8

7 January 2021

The instructive role of innate immunity in the acquired immune response

1 reference

https://api.crossref.org/works/10.1016%2FS1043-4666%2802%2900490-8

7 January 2021

The role of interleukin-6 in mucosal IgA antibody responses in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1043-4666%2802%2900490-8

7 January 2021

Receptors for B cell stimulatory factor 2. Quantitation, specificity, distribution, and regulation of their expression

1 reference

https://api.crossref.org/works/10.1016%2FS1043-4666%2802%2900490-8

7 January 2021

Intravesical instillations of interferon gamma in the prophylaxis of high risk superficial bladder cancer--results of a controlled prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1043-4666%2802%2900490-8

7 January 2021

New use of BCG for recombinant vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS1043-4666%2802%2900490-8

7 January 2021

10.1016/S1043-4666(02)00490-8

Identifiers

DOI

1 reference

22 September 2017

1 reference